Ralf Ulrich Trappe

Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial

Ralf Ulrich Trappe, Stephan Oertel, Véronique Leblond et al. · The Lancet Oncology · 2011 · 386 citations

Medicine, Immunology, Oncology +9

Prognostic factors for remission of and survival in acquired hemophilia A (AHA): results from the GTH-AH 01/2010 study

Andreas Tiede, Robert Klamroth, Rüdiger E. Scharf et al. · Blood · 2014 · 285 citations · Full text

Medicine, Hematology, Survival Analysis +10

MECP2 Mutations in Sporadic Cases of Rett Syndrome Are Almost Exclusively of Paternal Origin

Ralf Ulrich Trappe, Franco Laccone, Joana Cobilanschi et al. · The American Journal of Human Genetics · 2001 · 283 citations · Full text

Life Sciences, Genetics, Molecular Genetics +11

Effect of Anti‐CD 20 Antibody Rituximab in Patients with Post‐Transplant Lymphoproliferative Disorder (PTLD)

Stephan Oertel, Erik A.M. Verschuuren, Petra Reinke et al. · American Journal of Transplantation · 2005 · 259 citations

Life Sciences, Immunology, Pharmacotherapy +14

Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial

Viola Poeschel, Gerhard Held, Marita Ziepert et al. · The Lancet · 2019 · 253 citations · Full text

Medicine, Oncology, Cancer Immunology +10